Literature DB >> 16548907

Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence, and correlation with smoking habits and pulmonary function in Japanese male subjects.

Hisamitsu Omori1, Rumi Nakashima, Nobuko Otsuka, Yoshiko Mishima, Seigi Tomiguchi, Akiko Narimatsu, Yoshio Nonami, Shuichi Mihara, Wasaku Koyama, Tohru Marubayashi, Yasuo Morimoto.   

Abstract

OBJECTIVE: Screening with low-dose spiral CT is a promising new tool for early lung cancer detection. A study was undertaken to assess the prevalence of emphysema detected by CT screening, and to assess the correlation between the extent of emphysema and the severity defined according to the recently published Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria.
METHODS: After informed consent, CT screening and pulmonary function tests were performed on 615 men between the ages of 40 and 69. Severity of emphysema was assessed visually. Only the pulmonary function data for male subjects were analysed because there were too few female subjects with emphysema.
RESULTS: Emphysema was detected in 30.5% of current smokers, 14.1% of former smokers and 3.0% of non-smokers. In male current smokers, airflow obstruction (FEV(1)/FVC < 0.7) was seen in 18.1% of subjects with mild emphysema, and in 33.3% of subjects with moderate emphysema. FEV(1) values were less than 80% of the predicted normal in 8.5% of subjects with mild emphysema, and 28.6% of subjects with moderate emphysema. The percentage of male subjects with emphysema equivalent to GOLD stage 0 was 90.0% for subjects in their 40s, 82.5% for those in their 50s, and 68.2% for those in their 60s.
CONCLUSION: A considerable percentage of the subjects with emphysema as detected by CT screening had GOLD stage 0. CT screening assists in detecting early-stage emphysema.

Entities:  

Mesh:

Year:  2006        PMID: 16548907     DOI: 10.1111/j.1440-1843.2006.00827.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  24 in total

1.  Low-dose multislice CT and high-resolution CT assessment of pulmonary emphysema in public school teachers.

Authors:  Noriaki Horiuchi; Jiro Fujita; Ichizo Suemitsu; Yasuhiro Yamasaki; Futoshi Higa; Masao Tateyama
Journal:  Lung       Date:  2007-02-09       Impact factor: 2.584

2.  Emphysema scores predict death from COPD and lung cancer.

Authors:  Javier J Zulueta; Juan P Wisnivesky; Claudia I Henschke; Rowena Yip; Ali O Farooqi; Dorothy I McCauley; Mildred Chen; Daniel M Libby; James P Smith; Mark W Pasmantier; David F Yankelevitz
Journal:  Chest       Date:  2011-10-20       Impact factor: 9.410

3.  Reconstruction algorithms influence the follow-up variability in the longitudinal CT emphysema index measurements.

Authors:  Bruno Hochhegger; Klaus Loureiro Irion; Edson Marchiori; Jose Silva Moreira
Journal:  Korean J Radiol       Date:  2011-03-03       Impact factor: 3.500

4.  Why do we need a nonhuman primate model of smoking-induced COPD?

Authors:  Jeffrey L Curtis; Christine M Freeman
Journal:  Am J Pathol       Date:  2015-01-07       Impact factor: 4.307

Review 5.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

6.  Pulmonary emphysema subtypes on computed tomography: the MESA COPD study.

Authors:  Benjamin M Smith; John H M Austin; John D Newell; Belinda M D'Souza; Anna Rozenshtein; Eric A Hoffman; Firas Ahmed; R Graham Barr
Journal:  Am J Med       Date:  2013-10-09       Impact factor: 4.965

Review 7.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

8.  Prevalence and correlates of pulmonary emphysema in smokers and former smokers. A densitometric study of participants in the ITALUNG trial.

Authors:  Gianna Camiciottoli; Edoardo Cavigli; Luca Grassi; Stefano Diciotti; Ilaria Orlandi; Marco Zappa; Giulia Picozzi; Andrea Lopes Pegna; Eugenio Paci; Fabio Falaschi; Mario Mascalchi
Journal:  Eur Radiol       Date:  2008-08-09       Impact factor: 5.315

9.  Evolution of emphysema in relation to smoking.

Authors:  Massimo Bellomi; Cristiano Rampinelli; Giulia Veronesi; Sergio Harari; Federica Lanfranchi; Sara Raimondi; Patrick Maisonneuve
Journal:  Eur Radiol       Date:  2009-08-25       Impact factor: 5.315

10.  Co-morbid disease in COPD--more than a coincidence.

Authors:  Alan J Crockett; David Price
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.